Ahmedabad: Zydus Lifesciences US based subsidiary, Sentynl Therapeutics, has received US FDA’s approval for its ZYCUBO® drug aimed at treating…
Trending
- How Entrepreneurs Can Support Breast Cancer Awareness Through Corporate Wellness Initiatives
- Tata Communications to invest $400–450 million in India’s ‘AI Super Highway’
- Why Are Indian Investors Funding Quick Commerce While Deeptech Startups Struggle to Raise Money?
- DAC Approves Rs 2.12 Lakh Crore Defence Procurement Proposals for Armed Forces
- Why Elon Musk believes most AI cloud startups could struggle to survive
- Anthropic sued over alleged unlicensed use of Elvis Presley songs to train Claude
- TDB-DST Signs ₹116 Crore Agreement with Manastu Space to Advance Indigenous Green Propulsion Technology
- Indian Railways plans to ease regulations for export cargo to attract export cargo, boost fleet reliability
